TrialCancer immunology, immunotherapy : CII2012

Assessment of association between BRAF-V600E mutation status in melanomas and clinical response to ipilimumab.

Vafa Shahabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.